Global burden and trends of testicular cancer in adolescents and young adults from 1990 to 2021, with predictions to 2035

被引：1
作者：
Yu, Shengjian [1 ]
Guo, Zeying [2 ]
Qiu, Zijian [3 ]
Wang, Liejiong [1 ]
Chen, Xiuxia [4 ]
Xuan, Feng [1 ]
机构：
[1] Wenzhou Med Univ, Zhuji Affiliated Hosp, Dept Radiat Oncol, Shaoxing, Peoples R China
[2] Wenzhou Med Univ, Zhuji Affiliated Hosp, Dept Med Oncol, Shaoxing, Peoples R China
[3] Wenzhou Med Univ, Quzhou Peoples Hosp, Quzhou Affiliated Hosp, Dept Radiat Oncol, Quzhou, Peoples R China
[4] Wenzhou Med Univ, Zhuji Affiliated Hosp, Dept Pathol, Shaoxing, Peoples R China
来源：
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词：
Testicular cancer; Adolescents and young adults; GBD; 2021; Average annual percentage change; Decomposition analysis; Bayesian age-period-cohort model; EUROPE; RATES; RISK;
D O I：
10.1038/s41598-024-82897-4
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Testicular cancer predominantly affects adolescents and young adults (AYAs) aged 15-39 years. This study analyzed the global, regional, and national burden of testicular cancer among AYAs (1990 to 2021). Data from the Global Burden of Disease study was used to calculate age-standardized rates of incidence (ASIR), prevalence (ASPR), and disability-adjusted life years (ASDR). Trends were assessed using the Joinpoint regression and Bayesian age-period-cohort models, with projections up to 2035. Results showed the global ASIR of 4.05 (95% CI: 3.80-4.35), ASPR of 31.05 (95% CI: 28.88-33.68), and ASDR of 24.82 (95% CI: 22.99-26.91) per 100,000 in 2021, respectively. From 1990 to 2021, ASIR and ASPR increased, while ASDR remained relatively stable. Significant geographical disparities were observed, with Europe and Latin America showing higher burdens compared to Asia and Africa. The 25-29 age group had the highest age-specific rate of incidence (5.58; 95% UI: 5.25-5.97) and disability-adjusted life years (34.09; 95% UI: 31.55-37.11) per 100,000, while the 30-34 age group had the highest age-specific prevalence rate (43.12; 95% UI: 40.51-46.56) per 100,000 in 2021. By 2035, the global numbers of incidence and prevalence cases were projected to increase, with DALYs and age-standardized rates declining. These findings are crucial for informing global strategies in testicular cancer prevention.
引用
收藏
页数：17
相关论文
共 54 条
  • [1] Patrikidou A., Et al., European Association of Urology Guidelines on Testicular Cancer: 2023 update, Eur. Urol, 84, pp. 289-301, (2023)
  • [2] Miller K.D., Et al., Cancer statistics for adolescents and young adults, 2020, CA Cancer J. Clin, 70, pp. 443-459, (2020)
  • [3] McHugh D.J., Gleeson J.P., Feldman D.R., Testicular cancer in 2023: current status and recent progress, CA Cancer J. Clin, 74, pp. 167-186, (2024)
  • [4] Rajpert-De Meyts E., McGlynn K.A., Okamoto K., Jewett M.A.S., Bokemeyer C., Testicular germ cell tumours, Lancet, 387, pp. 1762-1774, (2016)
  • [5] Cheng L., Testicular cancer, . Nat. Rev. Dis. Primers, 4
  • [6] Zhou X., Et al., Trends in the global, regional, and national burden of testicular canc er from 1990 to 2019: an observational study with 30-year global data, Int. J. Surg, 110, pp. 4633-4647, (2024)
  • [7] Pishgar F., Et al., Global, regional and national burden of testicular cancer, 1990–2016: results from the global burden of Disease Study 2016, BJU Int, 124, pp. 386-394, (2019)
  • [8] Xu Y., Et al., Time trends in the mortality of testicular cancer across the BRICS: an age-period-cohort analysis for the GBD 2019, Sci. Rep, 14, (2024)
  • [9] Tverye A., Nangia A., Fantus R.J., Testicular cancer survivorship and fertility preservation, Urol. Clin. North. Am, 51, pp. 429-438, (2024)
  • [10] van Basten J.P., Et al., Sexual dysfunction in nonseminoma testicular cancer patients is relate d to chemotherapy-induced angiopathy, J. Clin. Oncol, 15, pp. 2442-2448, (1997)
123456